Koninklijke Philips | PHG - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Demant DKK 9.63B 241M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Fresenius EUR 5.25B 337M 2025-12
General Electric Aerospace USD 18.06B 7.11B 2026-03
Getinge SEK 9.99B 2.3B 2024-12
Globus Medical USD 645.11M 241.46M 2025-12
GN Store Nord DKK 4.11B 490M 2025-12
Hitachi JPY 2.4T 164.67B 2025-12
Idexx Laboratories USD 774.97M 24.58M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Koninklijke Philips EUR 5.1B 597.33M 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Philips EUR 4.38B 405M 2025-12
ResMed USD 925.21M 51.98M 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Steris USD 1.22B 28.8M 2025-12
Stryker USD 5.2B 505M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12